Quick Review and Technical Approach for Regenerative Peripheral Nerve Interface Surgery  

作　　者：Obed H Grajeda Chávez Andres Gallardo Castillo Samantha Colchado Mariscal Xunaxi Guadalupe Vázquez Orozco Dulce Sánchez Dauth Carlos Javier Mata Quintero Jorge Montalvo Hernández Ricardo Palacios Merino Minerva Irene Hernandez Cristian Diaz Solleiro Obed H Grajeda Chávez;Andres Gallardo Castillo;Samantha Colchado Mariscal;Xunaxi Guadalupe Vázquez Orozco;Dulce Sánchez Dauth;Carlos Javier Mata Quintero;Jorge Montalvo Hernández;Ricardo Palacios Merino;Minerva Irene Hernandez;Cristian Diaz Solleiro(Department of Surgery, Pemex Hospital Central Norte, Mexico City, Mexico)

机构地区：[1]Department of Surgery, Pemex Hospital Central Norte, Mexico City, Mexico

出　　处：《Modern Plastic Surgery》2023年第4期126-131,共6页现代整形外科（英文）

摘　　要：Regenerative peripheral nerve interface RPNI’s surgery was originally designed for prosthetic control. RPNI’s has demonstrated to be an effective tool to prevent neuroma formation by providing free muscle grafts as physiological targets for peripheral nerve ingrowth. Nerve transection injuries can result in painful neuromas that adversely affect patient recovery. This is especially significant following amputation surgeries, but they can also be used in surgeries in which the nerves can be visualized with a noticeable lesion. The first series of patients undergoing RPNI implantation for treatment of symptomatic postamputation neuromas was published in 2016. The series included a report of 46 patients undergoing RPNI. The clinical outcomes of RPNI have been optimistic with a reduction in neuroma pain up to 73% and phantom pain reduction of 53% along the uniformly high patient satisfaction. Since then, studies have been expanded, and knowledge regarding physiology has increased, providing us with new tools for a better understanding and giving these procedures more benefits and applications.Regenerative peripheral nerve interface RPNI’s surgery was originally designed for prosthetic control. RPNI’s has demonstrated to be an effective tool to prevent neuroma formation by providing free muscle grafts as physiological targets for peripheral nerve ingrowth. Nerve transection injuries can result in painful neuromas that adversely affect patient recovery. This is especially significant following amputation surgeries, but they can also be used in surgeries in which the nerves can be visualized with a noticeable lesion. The first series of patients undergoing RPNI implantation for treatment of symptomatic postamputation neuromas was published in 2016. The series included a report of 46 patients undergoing RPNI. The clinical outcomes of RPNI have been optimistic with a reduction in neuroma pain up to 73% and phantom pain reduction of 53% along the uniformly high patient satisfaction. Since then, studies have been expanded, and knowledge regarding physiology has increased, providing us with new tools for a better understanding and giving these procedures more benefits and applications.

关 键 词：Component Formatting STYLE STYLING INSERT 

分 类 号：R73[医药卫生—肿瘤]